Skip to Content

Protected: Cardiology Training

Plasma Ceramides - Part 2

Presenters: Drs. Jeffrey Meeusen, Francisco Lopez-Jimenez, and Reijo Laaksonen
Presentation At-A-Glance:

  • Ceramides are a novel biomarker of lipid dysfunction, inflammation, thrombotic risk, and cardiac damage.
  • Ceramides predict adverse cardiovascular events in primary and secondary prevention.
  • Ceramides are treatable with statins and possibly PCSK9 inhibitors.
  • Ceramides associate especially with major adverse events and cardiovascular death.
  • Ceramides outperform all currently used lipid biomarkers.
  • Ceramide score is an easy way to summarize ceramide concentrations and ratios.

Plasma Ceramides - Part 1

Presenter: Jeffrey Meeusen, Ph.D.
Presentation At-A-Glance:

  • Ceramides predict adverse CV events in patients with CAD.
  • Ceramides are a modifiable risk marker (statin therapies significantly reduce ceramides).
  • Research shows that ceramides outperform other common biomarkers in the prediction of CV death.

Cardiology 101

Presenter: Jill Nagel, P.A.-C.
Presentation At-A-Glance:

  • Provide a basic, high level overview of cardiology.
  • Share a high level overview of cardiology disease states.